Literature DB >> 19858307

Genetic fusions of heat-labile (LT) and heat-stable (ST) toxoids of porcine enterotoxigenic Escherichia coli elicit neutralizing anti-LT and anti-STa antibodies.

Weiping Zhang1, Chengxian Zhang, David H Francis, Ying Fang, David Knudsen, James P Nataro, Donald C Robertson.   

Abstract

Enterotoxigenic Escherichia coli (ETEC) strains are a major cause of diarrheal disease in humans and farm animals. E. coli fimbriae, or colonization factor antigens (CFAs), and enterotoxins, including heat-labile enterotoxins (LT) and heat-stable enterotoxins (ST), are the key virulence factors in ETEC diarrhea. Unlike fimbriae or LT, STa has not often been included as an antigen in development of vaccines against ETEC diarrhea because of its poor immunogenicity. STa becomes immunogenic only after being coupled with a strongly immunogenic carrier protein. However, native or shorter STa antigens either had to retain toxic activity in order to become antigenic or elicited anti-STa antibodies that were not sufficiently protective. In this study, we genetically mutated the porcine LT (pLT) gene for a pLT(192(R-->G)) toxoid and the porcine STa (pSTa) gene for three full-length pSTa toxoids [STa(11(N-->K)), STa(12(P-->F)), and STa(13(A-->Q))] and used the full-length pLT(192) as an adjuvant to carry the pSTa toxoid for pLT(192):pSTa-toxoid fusion antigens. Rabbits immunized with pLT(192):pSTa(12) or pLT(192):pSTa(13) fusion protein developed high titers of anti-LT and anti-STa antibodies. Furthermore, rabbit antiserum and antifecal antibodies were able to neutralize purified cholera toxin (CT) and STa toxin. In addition, preliminary data suggested that suckling piglets born by a sow immunized with the pLT(192):pSTa(13) fusion antigen were protected when challenged with an STa-positive ETEC strain. This study demonstrated that pSTa toxoids are antigenic when fused with a pLT toxoid and that the elicited anti-LT and anti-STa antibodies were protective. This fusion strategy could provide instructive information to develop effective toxoid vaccines against ETEC-associated diarrhea in animals and humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19858307      PMCID: PMC2798211          DOI: 10.1128/IAI.00497-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Full capacity of recombinant Escherichia coli heat-stable enterotoxin fusion proteins for extracellular secretion, antigenicity, disulfide bond formation, and activity.

Authors:  I Batisson; M Der Vartanian; B Gaillard-Martinie; M Contrepois
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Fimbriae and enterotoxins associated with Escherichia coli serogroups isolated from pigs with colibacillosis.

Authors:  R A Wilson; D H Francis
Journal:  Am J Vet Res       Date:  1986-02       Impact factor: 1.156

3.  Lysine residue 117 of the FasG adhesin of enterotoxigenic Escherichia coli is essential for binding of 987P fimbriae to sulfatide.

Authors:  B K Choi; D M Schifferli
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

4.  Permissive linker insertion sites in the outer membrane protein of 987P fimbriae of Escherichia coli.

Authors:  D M Schifferli; M A Alrutz
Journal:  J Bacteriol       Date:  1994-02       Impact factor: 3.490

5.  Observations on the pathogenic properties of the K88, Hly and Ent plasmids of Escherichia coli with particular reference to porcine diarrhoea.

Authors:  H W Smith; M A Linggood
Journal:  J Med Microbiol       Date:  1971-11       Impact factor: 2.472

Review 6.  Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli.

Authors:  M K Wolf
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

7.  Immunity to enterotoxigenic Escherichia coli.

Authors:  M M Levine; D R Nalin; D L Hoover; E J Bergquist; R B Hornick; C R Young
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

8.  Development of a competitive enzyme-linked immunosorbent assay (ELISA) for Escherichia coli heat-stable enterotoxin (STa).

Authors:  D E Lockwood; D C Robertson
Journal:  J Immunol Methods       Date:  1984-12-31       Impact factor: 2.303

9.  Significance of heat-stable and heat-labile enterotoxins in porcine colibacillosis in an additive model for pathogenicity studies.

Authors:  Weiping Zhang; Emil M Berberov; Jessica Freeling; D He; Rodney A Moxley; David H Francis
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

10.  Escherichia coli constructs expressing human or porcine enterotoxins induce identical diarrheal diseases in a piglet infection model.

Authors:  Weiping Zhang; Donald C Robertson; Chengxian Zhang; Wei Bai; Mojun Zhao; David H Francis
Journal:  Appl Environ Microbiol       Date:  2008-07-25       Impact factor: 4.792

View more
  42 in total

Review 1.  Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target.

Authors:  Arne Taxt; Rein Aasland; Halvor Sommerfelt; James Nataro; Pål Puntervoll
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

2.  Immunogenicity of nuclear-encoded LTB:ST fusion protein from Escherichia coli expressed in tobacco plants.

Authors:  Sergio Rosales-Mendoza; Ruth E Soria-Guerra; Leticia Moreno-Fierros; Dania O Govea-Alonso; Areli Herrera-Díaz; Schuyler S Korban; Ángel G Alpuche-Solís
Journal:  Plant Cell Rep       Date:  2011-02-12       Impact factor: 4.570

Review 3.  Animal Enterotoxigenic Escherichia coli.

Authors:  J Daniel Dubreuil; Richard E Isaacson; Dieter M Schifferli
Journal:  EcoSal Plus       Date:  2016-10

4.  Multiepitope fusion antigen induces broadly protective antibodies that prevent adherence of Escherichia coli strains expressing colonization factor antigen I (CFA/I), CFA/II, and CFA/IV.

Authors:  Xiaosai Ruan; David E Knudsen; Katie M Wollenberg; David A Sack; Weiping Zhang
Journal:  Clin Vaccine Immunol       Date:  2013-12-18

5.  Immunogenicity characterization of genetically fused or chemically conjugated heat-stable toxin toxoids of enterotoxigenic Escherichia coli in mice and pigs.

Authors:  Hyesuk Seo; Ti Lu; Rahul M Nandre; Qiangde Duan; Weiping Zhang
Journal:  FEMS Microbiol Lett       Date:  2019-02-01       Impact factor: 2.742

6.  Yeast Surface Display of Escherichia coli Enterotoxin and Its Effects of Intestinal Microflora and Mucosal Immunity.

Authors:  ShiYu Li; Zhou Sha; Xiaoxu Wang; Zhaoyang Bu; Li Wang; Xiaohui Guan; Xulong Lang; Xinglong Wang
Journal:  Curr Microbiol       Date:  2017-05-02       Impact factor: 2.188

7.  Enterotoxigenic Escherichia coli Adhesin-Toxoid Multiepitope Fusion Antigen CFA/I/II/IV-3xSTaN12S-mnLTG192G/L211A-Derived Antibodies Inhibit Adherence of Seven Adhesins, Neutralize Enterotoxicity of LT and STa Toxins, and Protect Piglets against Diarrhea.

Authors:  Rahul Nandre; Xiaosai Ruan; Ti Lu; Qiangde Duan; David Sack; Weiping Zhang
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

8.  Characterization of immunological cross-reactivity between enterotoxigenic Escherichia coli heat-stable toxin and human guanylin and uroguanylin.

Authors:  Arne M Taxt; Yuleima Diaz; Amélie Bacle; Cédric Grauffel; Nathalie Reuter; Rein Aasland; Halvor Sommerfelt; Pål Puntervoll
Journal:  Infect Immun       Date:  2014-04-28       Impact factor: 3.441

9.  Characterization of heat-stable (STa) toxoids of enterotoxigenic Escherichia coli fused to double mutant heat-labile toxin peptide in inducing neutralizing Anti-STa antibodies.

Authors:  Xiaosai Ruan; Donald C Robertson; James P Nataro; John D Clements; Weiping Zhang
Journal:  Infect Immun       Date:  2014-02-18       Impact factor: 3.441

10.  Neutralizing Anti-Heat-Stable Toxin (STa) Antibodies Derived from Enterotoxigenic Escherichia coli Toxoid Fusions with STa Proteins Containing N12S, L9A/N12S, or N12S/A14T Mutations Show Little Cross-Reactivity with Guanylin or Uroguanylin.

Authors:  Qiangde Duan; Jiachen Huang; Nan Xiao; Hyesuk Seo; Weiping Zhang
Journal:  Appl Environ Microbiol       Date:  2018-01-02       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.